These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35896334)

  • 21. Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis.
    Kang SE; Park JK; Yoo HJ; Kang HS; Park YW; Park BC; Park JE; Lee EY; Lee EB; Song YW
    Transl Res; 2021 Jun; 232():75-87. PubMed ID: 33453429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
    Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK
    Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterotrimers formed by tumor necrosis factors of different species or muteins.
    Ameloot P; Declercq W; Fiers W; Vandenabeele P; Brouckaert P
    J Biol Chem; 2001 Jul; 276(29):27098-103. PubMed ID: 11371574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells.
    Rossol M; Meusch U; Pierer M; Kaltenhäuser S; Häntzschel H; Hauschildt S; Wagner U
    J Immunol; 2007 Sep; 179(6):4239-48. PubMed ID: 17785864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies.
    Bar-Yoseph H; Pressman S; Blatt A; Gerassy Vainberg S; Maimon N; Starosvetsky E; Ungar B; Ben-Horin S; Shen-Orr SS; Chowers Y;
    Gastroenterology; 2019 Nov; 157(5):1338-1351.e8. PubMed ID: 31401142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.
    Lewis M; Tartaglia LA; Lee A; Bennett GL; Rice GC; Wong GH; Chen EY; Goeddel DV
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2830-4. PubMed ID: 1849278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering.
    Iwayanagi Y; Igawa T; Maeda A; Haraya K; Wada NA; Shibahara N; Ohmine K; Nambu T; Nakamura G; Mimoto F; Katada H; Ito S; Tachibana T; Jishage K; Hattori K
    J Immunol; 2015 Oct; 195(7):3198-205. PubMed ID: 26320252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prepared and screened a modified TNF-alpha molecule as TNF-alpha autovaccine to treat LPS induced endotoxic shock and TNF-alpha induced cachexia in mouse.
    Wan Y; Xue X; Li M; Zhang X; Qin X; Zhang C; You Y; Wang W; Jiang C; Wu S; Liu Y; Zhu W; Ran Y; Zhang Z; Han W; Zhang Y
    Cell Immunol; 2007 Apr; 246(2):55-64. PubMed ID: 17592730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies.
    Sisto M; Lisi S; Lofrumento DD; Frassanito MA; Cucci L; D'Amore S; Mitolo V; D'Amore M
    Int Immunol; 2009 Dec; 21(12):1341-9. PubMed ID: 19854762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab.
    Bian S; Ferrante M; Gils A
    AAPS J; 2017 Mar; 19(2):468-474. PubMed ID: 27873119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a novel anti-human TNF-alpha murine monoclonal antibody with high binding affinity and neutralizing activity.
    Song MY; Park SK; Kim CS; Yoo TH; Kim B; Kim MS; Kim YS; Kwag WJ; Lee BK; Baek K
    Exp Mol Med; 2008 Feb; 40(1):35-42. PubMed ID: 18305396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reprint of "Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab".
    Cludts I; Spinelli FR; Morello F; Hockley J; Valesini G; Wadhwa M
    Cytokine; 2018 Jan; 101():70-77. PubMed ID: 29174881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome.
    Armstrong L; Thickett DR; Christie SJ; Kendall H; Millar AB
    Am J Respir Cell Mol Biol; 2000 Jan; 22(1):68-74. PubMed ID: 10615067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysis.
    Meroni PL; Valentini G; Ayala F; Cattaneo A; Valesini G
    Autoimmun Rev; 2015 Sep; 14(9):812-29. PubMed ID: 25985765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
    Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
    Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole cell-based surface plasmon resonance measurement to assess binding of anti-TNF agents to transmembrane target.
    Ogura T; Tanaka Y; Toyoda H
    Anal Biochem; 2016 Sep; 508():73-7. PubMed ID: 27349512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells.
    Kleijwegt FS; Laban S; Duinkerken G; Joosten AM; Zaldumbide A; Nikolic T; Roep BO
    J Immunol; 2010 Aug; 185(3):1412-8. PubMed ID: 20574005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained secretion of anti-tumor necrosis factor α monoclonal antibody from ex vivo genetically engineered dermal tissue demonstrates therapeutic activity in mouse model of rheumatoid arthritis.
    Zafir-Lavie I; Miari R; Sherbo S; Krispel S; Tal O; Liran A; Shatil T; Badinter F; Goltsman H; Shapir N; Benhar I; Neil GA; Panet A
    J Gene Med; 2017 Aug; 19(8):. PubMed ID: 28658716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.
    Bar-Yoseph H; Blatt A; Gerassy S; Pressman S; Mousa A; Sabo E; Waterman M; Ungar B; Ben-Horin S; Chowers Y
    J Crohns Colitis; 2022 Jul; 16(6):884-892. PubMed ID: 34849649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity.
    Xu H; Uysal KT; Becherer JD; Arner P; Hotamisligil GS
    Diabetes; 2002 Jun; 51(6):1876-83. PubMed ID: 12031976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.